Why is Lucid Diagnostics, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 41.69% and Operating profit at -231.92% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -49.47
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -14.29%, its profits have fallen by -7.7%
3
Below par performance in long term as well as near term
- Along with generating -14.29% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lucid Diagnostics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Lucid Diagnostics, Inc.
-14.29%
0.71
62.97%
S&P 500
25.41%
1.92
13.25%
Quality key factors
Factor
Value
Sales Growth (5y)
41.69%
EBIT Growth (5y)
-231.92%
EBIT to Interest (avg)
-49.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.57
Sales to Capital Employed (avg)
0.14
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
27.06%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
18.12
EV to EBIT
-3.79
EV to EBITDA
-3.86
EV to Capital Employed
167.59
EV to Sales
40.03
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4416.46%
ROE (Latest)
-450.59%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Movement
8What is working for the Company
NET SALES(HY)
At USD 2.76 MM has Grown at 36.3%
NET PROFIT(HY)
Higher at USD -25.96 MM
ROCE(HY)
Highest at 0%
RAW MATERIAL COST(Y)
Fallen by -58.22% (YoY
-6What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -46.12 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 7.31 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 13.69 times
Here's what is working for Lucid Diagnostics, Inc.
Net Sales
At USD 2.76 MM has Grown at 36.3%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD -25.96 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -58.22% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lucid Diagnostics, Inc.
Operating Cash Flow
Lowest at USD -46.12 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Inventory Turnover Ratio
Lowest at 7.31 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Debtors Turnover Ratio
Lowest at 13.69 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio






